Stock PUR PURE BIOLOGICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Pure Biologics S.A.

Equities

PUR

PLPRBLG00010

Biotechnology & Medical Research

Market Closed - Warsaw S.E.
Other stock markets
 09:25:43 02/05/2024 pm IST 		5-day change 1st Jan Change
7.83 PLN -0.25% Intraday chart for Pure Biologics S.A. -1.51% -38.05%
2023 Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Pure Biologics SA is a manufacturer of biological products. The Company was founded in August 2010 and is located in Wroclaw, Poland.

Number of employees: 96

Sales per Business

PLN in Million2021Weight2022Weight Delta
Services
98.0 %
0 54.7 % 1 98.0 % +366.91%
Other
2.0 %
0 45.3 % 0 2.0 % -88.70%

Sales per region

PLN in Million2021Weight2022Weight Delta
Poland
100.0 %
0 100.0 % 1 100.0 % +160.63%

Managers

Managers TitleAgeSince
Maciej Piotr Mazurek FOU
 Founder - 01/10/01
Filip Jan Jelen CEO
 Chief Executive Officer 47 01/10/01
Romuald Harwas DFI
 Director of Finance/CFO 52 16/19/16
Aldona Pietraszek ADM
 Chief Administrative Officer - -
Przemyslaw Dudek CTO
 Chief Tech/Sci/R&D Officer - 01/18/01
Pieter Spee CTO
 Chief Tech/Sci/R&D Officer 55 26/23/26
Marta Wawrzyniak COO
 Chief Operating Officer - -
Martyna Koj IRC
 Investor Relations Contact - -
Michal Surma PRN
 Corporate Officer/Principal - 01/19/01
Marta Rot HRO
 Human Resources Officer - 01/19/01

Members of the board

Members of the board TitleAgeSince
Tadeusz Wesolowski BRD
 Director/Board Member 72 07/19/07
Andrzej Jan Trznadel FOU
 Founder 62 01/10/01
Pawel Marcin Wisniewski BRD
 Director/Board Member 44 26/23/26
Mariusz Czekala BRD
 Director/Board Member 65 09/19/09
Julia Krystyna Bar BRD
 Director/Board Member 68 12/20/12

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,214,000 2,748,163 ( 85.51 %) 0 85.51 %

Shareholders

NameEquities%Valuation
Allianz Polska TFI SA
1.988 %
66,153 1.988 % 134 205 zł
Aviva Investors Poland Towarzystwo Funduszy Inwestycyjnych SA
1.835 %
61,049 1.835 % 123 851 zł
ESALIENS TFI SA
0.7843 %
26,100 0.7843 % 52 949 zł

Company contact information

Pure Biologics SA

Dunska Street 11

54-427, Wroclaw

+48 795 61 18 11

http://www.purebiologics.com
address Pure Biologics S.A.(PUR)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PURE BIOLOGICS S.A. Stock Pure Biologics S.A.
-38.05% 6.45M
MODERNA, INC. Stock Moderna, Inc.
+26.28% 42.68B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-3.99% 42.4B
LONZA GROUP AG Stock Lonza Group AG
+45.32% 40.04B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.36% 24.94B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.47% 18.96B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.58% 12.3B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.75% 11.95B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-2.02% 11.55B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PUR Stock
  4. Company Pure Biologics S.A.